Objective To determine the success of ablative treatment using fixed high doses of 131 I in
patients with thyroid cancer. Methods A retrospective study was conducted on 274 patients …

Purpose Iodine-123 is a pure gamma emitter and has excellent characteristics for imaging
with modern scintillation cameras. The goal of this study was to compare the performance of …

Objective: Current guidelines have advised against the performance of 131I-iodide
diagnostic whole body scintigraphy (dxWBS) to minimize the occurrence of stunning, and to …

Summary objective Previous studies have shown a high rate of visualization of uptake and a
decrease in serum thyroglobulin (Tg) after therapeutic doses of 131I in well‐differentiated …

Summary objective To evaluate the risk of performing inappropriate 131I ablative therapies
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …

Aim of Study: The aim of this study was to compare pretherapy diagnostic I-123 scans with 7-
day posttherapy I-131 scans days in detecting remnant thyroid disease as well as …

Nonspecific 131I uptake may affect both the specificity and the accuracy of whole-body
scanning (WBS) performed after 131I administration in the follow-up of thyroid carcinoma …

Purpose Existence and cause of thyroid stunning was controversially discussed for decades
but the underlying mechanism remains unclear. Numerous studies describe thyroid stunning …

Fifty seven patients with differentiated thyroid carcinoma were performed radioactive iodine-
131 whole body scans after administration of diagnostic dose $(2\sim10\; mCi) $ and …

Objective To determine whether 123 I can be used as a safe and effective alternative tracer
to 131 I for imaging remnant tissue and for searching for metastatic lesions of well …